Search results

Narrow your search

Result types

Showing 1001 - 1010 of 2019 for "DeHeng Law Offices" with applied filters

News & Analysis

IP Courts Revisiting the Scope of Claims Amendment

20 November 2023 by LexOrbis : Neha Ruhela (Senior Associate)

After the milestone verdict of the Delhi High Court in Allergan v Controller (2023:DHC:515), now it is time for patent strategists to rejoice over landmark judgments of the Madras High Court, including Starpharma Pty Ltd. v Controller (2023/MHC/4638) that provide similar liberal interpretations of amendment of claims under Section 59 of the Patents Act, 1970.

News & Analysis

Shardul Amarchand Mangaldas advises Ring Plus Aqua Limited on the strategic acquisition of 59.25% stake in Maini Precision Products Limited

13 November 2023 by Shardul Amarchand Mangaldas & Co - India

10 November 2023 | New Delhi: Shardul Amarchand Mangaldas advised Ring Plus Aqua Limited (“RPAL”) on the strategic acquisition of 59.25% stake in Maini Precision Products Limited (“MPPL”), an entity engaged in the business of manufacturing

News & Analysis

Guidelines on Foreign Exchange Business of Foreign Financial Institutions

13 November 2023 by Lee & Ko - South Korea

On October 18, 2023, the Guidelines on Foreign Exchange Business of Foreign Financial Institutions (the Guidelines) were established and implemented to open the domestic foreign exchange market to the outside world.

News & Analysis

Amendments to the Financial Investment Services and Capital Markets Act: New Sanctions Against Unfair Trading Activities

06 November 2023 by Jipyong - South Korea

On September 25, 2023, Korea’s Financial Services Commission (“FSC”) announced a legislative notice for a proposed amendment to the Enforcement Decree of the Financial Investment Services and Capital Markets Act (the “FSCMA”).

News & Analysis

Relooking at the reach of Section 3(d) of the Indian Patents Act, 1970 after ‘Novozymes’ Case

30 October 2023 by LexOrbis - DPS Parmar

Section 3(d) of the Indian Patents Act, 1970 was never so controversial till the insertion of an amendment in 2005, which states that “the mere discovery of a new form of a known substance which does not result in the enhancement of the known efficacy of that substance".

News & Analysis

Analysing the Department of Biotechnology (DBT) Intellectual Property Guidelines 2023

16 October 2023 by LexOrbis - India : Manisha Singh (Partner) & Shikha Singh (Managing Associate)

With increasing awareness of securing intellectual property rights and deriving value from them, the commercialisation of patents is an important aspect.

News & Analysis

MOJ Announces Amendments to the Korean Commercial Act to Reinforce Regulations on Corporate Governance and Protection of Shareholders

10 October 2023 by Jipyong - South Korea

On August 24, 2023, the Ministry of Justice (the “MOJ”) announced partial amendments to the Commercial Act of Korea to bolster regulations on corporate governance and protection of shareholders.

News & Analysis

Shailyamanyu Singh joins Anand and Anand as a Partner Designate in IP and Corporate Practice.

26 September 2023 by Anand and Anand

Shailyamanyu Singh has 24 years of legal experience and started his career as a Litigation counsel in Punjab & Haryana High Court and an IP practice.

News & Analysis

Han Kun Releases Its 2022 VC/PE Data Analysis Report

18 September 2023 by Han Kun Law Offices - China

Onshore Transactions Continued their Upward Trend, the Biomedical Sector Remained the Most Popular Investment Destination

News & Analysis

Yuen Law Shortlisted As Finalist for ALB Regulatory Law Firm of the Year

15 September 2023 by Yuen Law

Yuen Law has been shortlisted as finalist for the prestigious Regulatory Law Firm of the Year award at the Asian Legal Business (ALB) Pan Asian Regulatory Summit Awards 2023/2024.